Increased thickness of pregnancy-associated melanoma
- 1 June 1995
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 132 (6) , 876-883
- https://doi.org/10.1111/j.1365-2133.1995.tb16942.x
Abstract
Summary The effects of pregnancy on the pathophysiology of melanoma remain unclear. Although a gender-specific advantage for women vs. men is seen for characteristics such as stage at presentation, site of primary tumour, and survival time, an adverse effect of pregnancy on melanoma development and progression has been reported. In a retrospective study, we investigated the tumour characteristics of women who developed pregnancy-associated melanoma, and compared them with melanomas arising in non-pregnant women of child-bearing age. The patient records of the Massachusetts General Hospital Pigmented Lesion Clinic were reviewed, and 465 women of reproductive age (16–45 years) who developed melanoma were identified. Of these, in 45 women (age 21–42 years) there was a close temporal relationship between diagnosis of the tumour and pregnancy. Clinical and histological characteristics of the primary tumours were recorded. Differences in tumour thickness, site and histological type were analysed. The mean thickness of pregnancy-associated melanomas was significantly greater than that of non-pregnancy-associated tumours (2.28 vs. 1.22 mm, respectively: P < 0.007). No differences in histological type (P = 0.64) or site (P = 0.74) of the primary tumours were found between the two patient groups. Not surprisingly, multivariate analysis revealed that tumour thickness was a statistically significant variable in determining prognosis (P = 0001). An unexpected finding, on multivariate analysis, was a possible pregnancy-associated prognostic advantage (P = 008). Melanomas arising during pregnancy are thicker, but are not necessarily associated with a less favourable prognosis than tumours arising in non-pregnant women of child-bearing age. The mechanisms by which pregnancy may lead to increased thickness of melanoma have yet to be elucidated, and merit further study.Keywords
This publication has 31 references indexed in Scilit:
- Influence of gender on survival in patients with stage I malignant melanomaJournal of the American Academy of Dermatology, 1992
- Pregnancy and sex steroid hormone effects on nevi of patients with the dysplastic nevus syndromeJournal of the American Academy of Dermatology, 1991
- Absence of estrogen receptors in dysplastic nevi and malignant melanomaJournal of the American Academy of Dermatology, 1990
- Malignant Melanoma Arising During PregnancyAnnals of Surgery, 1990
- The effect of pregnancy on hormone levels and receptors in malignant melanomaJournal of Surgical Oncology, 1983
- The Natural Break Points for Primary-Tumor Thickness in Clinical Stage I MelanomaNew England Journal of Medicine, 1981
- Malignant melanoma of the skin occurring during pregnancyCancer, 1981
- MALIGNANT MELANOMA: AN ANDROGEN-DEPENDENT TUMOUR?The Lancet, 1980
- Tamoxifen in Malignant MelanomaNew England Journal of Medicine, 1979
- Human Chorionic Gonadotropin: Its Possible Role in Maternal Lymphocyte SuppressionScience, 1973